Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 16, 2023; 11(32): 7911-7919
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7911
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7911
Figure 3 Histopathological and immunohistochemical features of Case 2.
A and B: Tumor cells had no clear differentiation, glandular morphology and mucoid interstitial substance could be observed in some areas. (Hematoxylin and eosin staining, ×200); C-J: The tumor cells were diffuse positivity for CK(x100), CK8/18 (×100), partial positivity for P40 (×100), P63 (×100), S-100 (×100), Syn (×100), and negativity for CK7 (×100), LCA (×100); K: Tumors had a PD-L1 combined positive score of one (×100); L: The Ki-67 proliferative index was approximately 70% (×100).
- Citation: Zhang L, Gao AX, He YL, Xu MJ, Lu HJ. Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports. World J Clin Cases 2023; 11(32): 7911-7919
- URL: https://www.wjgnet.com/2307-8960/full/v11/i32/7911.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i32.7911